Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 40

1.

Ageing Renal Patients: We Need More Collaboration between Geriatric Services and Nephrology Departments.

Alston H, Burns A.

Healthcare (Basel). 2015 Oct 30;3(4):1075-85. doi: 10.3390/healthcare3041075. Review.

2.

Nonalcoholic fatty liver disease is associated with cognitive function in adults.

Seo SW, Gottesman RF, Clark JM, Hernaez R, Chang Y, Kim C, Ha KH, Guallar E, Lazo M.

Neurology. 2016 Mar 22;86(12):1136-42. doi: 10.1212/WNL.0000000000002498. Epub 2016 Feb 24.

PMID:
26911638
3.
4.

The burden of comorbidity in people with chronic kidney disease stage 3: a cohort study.

Fraser SD, Roderick PJ, May CR, McIntyre N, McIntyre C, Fluck RJ, Shardlow A, Taal MW.

BMC Nephrol. 2015 Dec 1;16:193. doi: 10.1186/s12882-015-0189-z.

5.

Renal function and long-term decline in cognitive function: the Baltimore Longitudinal Study of Aging.

Seliger SL, Wendell CR, Waldstein SR, Ferrucci L, Zonderman AB.

Am J Nephrol. 2015;41(4-5):305-12. doi: 10.1159/000430922. Epub 2015 Jun 6.

6.

The role of Th1 and Th17 cells in glomerulonephritis.

Azadegan-Dehkordi F, Bagheri N, Shirzad H, Rafieian-Kopaei M.

J Nephropathol. 2015 Apr;4(2):32-7. doi: 10.12860/jnp.2015.07. Epub 2015 Mar 19. Review.

7.

Psychomotor functions at various weeks of chronic renal failure in rats.

Chandanathil MI, Upadhya S, Upadhya S, Bhat G.

Cogn Neurodyn. 2015 Apr;9(2):201-11. doi: 10.1007/s11571-014-9315-z. Epub 2014 Oct 28.

8.

Kidney disease as a determinant of cognitive decline and dementia.

Etgen T.

Alzheimers Res Ther. 2015 Mar 17;7(1):29. doi: 10.1186/s13195-015-0115-4. eCollection 2015.

9.

Duration of chronic kidney disease reduces attention and executive function in pediatric patients.

Mendley SR, Matheson MB, Shinnar S, Lande MB, Gerson AC, Butler RW, Warady BA, Furth SL, Hooper SR.

Kidney Int. 2015 Apr;87(4):800-6. doi: 10.1038/ki.2014.323. Epub 2014 Sep 24.

10.

Chapter 1: Definition and classification of CKD.

[No authors listed]

Kidney Int Suppl (2011). 2013 Jan;3(1):19-62. No abstract available.

11.

Effects of three blood purification methods on serum fibroblast growth factor-23 clearance in patients with hyperphosphatemia undergoing maintenance hemodialysis.

Miao LY, Zhu B, He XZ, Liu JF, Jin LN, Li XR, Xue LN, Huang T, Shen JQ, Xing CY.

Exp Ther Med. 2014 Apr;7(4):947-952. Epub 2014 Feb 13.

12.

The association of Toxoplasma gondii infection with neurocognitive deficits in a population-based analysis.

Pearce BD, Kruszon-Moran D, Jones JL.

Soc Psychiatry Psychiatr Epidemiol. 2014 Jun;49(6):1001-10. doi: 10.1007/s00127-014-0820-5. Epub 2014 Jan 30.

13.

Electronically monitored medication adherence predicts hospitalization in heart failure patients.

Riegel B, Knafl GJ.

Patient Prefer Adherence. 2013 Dec 5;8:1-13. doi: 10.2147/PPA.S54520. eCollection 2013.

14.

Persistent viral pathogens and cognitive impairment across the life course in the third national health and nutrition examination survey.

Tarter KD, Simanek AM, Dowd JB, Aiello AE.

J Infect Dis. 2014 Mar;209(6):837-44. doi: 10.1093/infdis/jit616. Epub 2013 Nov 18.

15.

Altered pattern of spontaneous brain activity in the patients with end-stage renal disease: a resting-state functional MRI study with regional homogeneity analysis.

Liang X, Wen J, Ni L, Zhong J, Qi R, Zhang LJ, Lu GM.

PLoS One. 2013 Aug 22;8(8):e71507. doi: 10.1371/journal.pone.0071507. eCollection 2013.

16.

Albuminuria and cognitive decline in people with diabetes and normal renal function.

Barzilay JI, Lovato JF, Murray AM, Williamson J, Ismail-Beigi F, Karl D, Papademetriou V, Launer LJ.

Clin J Am Soc Nephrol. 2013 Nov;8(11):1907-14. doi: 10.2215/CJN.11321112. Epub 2013 Aug 29.

17.

Prevalence and pattern of neurocognitive impairment in nigerians with stages 3 to 5 chronic kidney disease.

Williams UE, Owolabi MO, Ogunniyi A, Ezunu EO.

ISRN Neurol. 2013 Jun 20;2013:374890. doi: 10.1155/2013/374890. Print 2013.

18.

Neuronal activation in the central nervous system of rats in the initial stage of chronic kidney disease-modulatory effects of losartan and moxonidine.

Palkovits M, Šebeková K, Klenovics KS, Kebis A, Fazeli G, Bahner U, Heidland A.

PLoS One. 2013 Jun 20;8(6):e66543. doi: 10.1371/journal.pone.0066543. Print 2013.

19.

Kidney disease and cognitive function.

Elias MF, Dore GA, Davey A.

Contrib Nephrol. 2013;179:42-57. doi: 10.1159/000346722. Epub 2013 May 3. Review.

20.

Relationship between longitudinal measures of renal function and onset of dementia in a community cohort of older adults.

O'Hare AM, Walker R, Haneuse S, Crane PK, McCormick WC, Bowen JD, Larson EB.

J Am Geriatr Soc. 2012 Dec;60(12):2215-22. doi: 10.1111/j.1532-5415.2012.04238.x.

Items per page

Supplemental Content

Write to the Help Desk